Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Cash Flow Reinvestment Rate
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Cash Flow Reinvestment Rate of 0.68x as of December 2025, reinvesting $27.77 Million (capex $27.77 Million ) from operating cash flow of $41.05 Million. Explore reinvestment intensity of Zhengye Biotechnology Holding Limited Or to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Also explore how large is Zhengye Biotechnology Holding Limited Or's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year capital reinvestment analysis for Zhengye Biotechnology Holding Limited Ordinary Shares. For live market cap and broader valuation context, see how much is Zhengye Biotechnology Holding Limited Or worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $27.77 Million | $41.05 Million | $27.77 Million | ▲ +39.5% |
| 2023 | 0.48x | $23.36 Million | $48.18 Million | $11.60 Million | ▼ -84.6% |
| 2022 | 3.15x | $54.66 Million | $17.34 Million | $27.33 Million | ▲ +90.4% |
| 2021 | 1.66x | $52.67 Million | $31.81 Million | $26.40 Million | — |